logobleu_nobaseline.jpg
Émission d’une 3ème tranche d’OC de 500.000€
January 26, 2022 11:45 ET | Deinove
Émission d’une 3ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
logobleu_nobaseline.jpg
Issuance of 3rd tranche of €500,000 of notes convertibles into new shares
January 26, 2022 11:45 ET | Deinove
Issuance of 3rd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
logobleu_nobaseline.jpg
Émission d’une 2ème tranche d’OC de 500.000€
December 15, 2021 11:45 ET | Deinove
Émission d’une 2ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
logobleu_nobaseline.jpg
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares
December 15, 2021 11:45 ET | Deinove
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
logobleu_nobaseline.jpg
Emission d’une 5ème tranche d'OCA de 3 m€
January 20, 2021 12:45 ET | Deinove
EMISSION D’UNE 5ème TRANCHE D'OCA DE 3 M€ DEINOVE renforce sa trésorerie pour financer la poursuite de l’essai clinique de DNV3837 dans le traitement des infections gastro-intestinales sévères...
logobleu_nobaseline.jpg
Issuance of a 5th tranche of 3 millions EUR of notes convertible into new shares
January 20, 2021 12:45 ET | Deinove
ISSUANCE OF A 5th TRANCHE OF 3 MILLIONS EUR OF NOTES CONVERTIBLE INTO NEW SHARES DEINOVE strengthens its cash position to finance the ongoing clinical trial testing DNV3837 for the treatment of...
LOGO.jpg
ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT
January 01, 2021 19:15 ET | The Rosen Law Firm PA
NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
LOGO.jpg
ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action – ICPT
December 10, 2020 17:28 ET | The Rosen Law Firm PA
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
LOGO.jpg
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT
December 03, 2020 19:45 ET | The Rosen Law Firm PA
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...